William Meury Karuna Therapeutics, Inc. (KRTX) insider trading activity

KRTX Quotes by TradingView

William Meury is President and CEO of Karuna Therapeutics, Inc.. Currently has a direct ownership of 0 shares of KRTX, which is worth approximately $0. The most recent transaction as insider was on Mar 18, 2024, when has been sold 29,379 shares (Common Stock) at a price of $330.0 per share, resulting in proceeds of $9,695,070. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

William Meury Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 18 2024
SELL
Sale (or disposition) back to the issuer
$9,695,070 $330.0 p/Share
29,379 Reduced 100.0%
0 Common Stock
Dec 28 2023
SELL
Payment of exercise price or tax liability
$2,749,912 $316.3 p/Share
8,694 Reduced 22.84%
29,379 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
38,073 Added 50.0%
38,073 Common Stock

Also insider at

SNDX
Syndax Pharmaceuticals Inc Healthcare
WM

William Meury

President and CEO
Waltham, MA

Track Institutional and Insider Activities on KRTX

Follow Karuna Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRTX shares.

Notify only if

Insider Trading

Get notified when an Karuna Therapeutics, Inc. insider buys or sells KRTX shares.

Notify only if

News

Receive news related to Karuna Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KRTX